ENTRY       D12232                      Drug
NAME        Litifilimab (USAN)
FORMULA     C6504H10020N1714O2047S42
EXACT_MASS  146232.0929
MOL_WEIGHT  146322.1372
SEQUENCE    (Heavy chain)
            DVQLVESGGG LVKPGGSLRL SCAASGFTFS TYTMSWVRQA PGKGLEWVAT ISPGDSFGYY
            YPDSVQGRFT ISRDNAKNSL YLQMNSLRAE DTAVYYCTRD IYYNYGAWFA YWGQGTLVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP G
            (Light chain)
            DIQLTQSPSS LSASVGDRVT ITCKASQSVD YDGDSYMNWY QQKPGKAPKL LIYAASTLES
            GVPSRFSGSG SGTDFTLTIS SLQPEDFATY YCQQANEDPR TFGQGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H97, H149-H205, H231-H'231, H234-H'234, H'255-L218, H266-H326, H372-H430, H'22-H'97, H'149-H'205, H'255-L'218, H'266-H'326, H'372-H'430, L23-L92, L138-L198, L'23-L'92, L'138-L'198)
  TYPE      Peptide
EFFICACY    Anti-inflammatory disease
  TYPE      Monoclonal antibody
COMMENT     Treatment of lupus
TARGET      CLEC4C (BDCA2, CD303) [HSA:170482] [KO:K06723]
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Pattern recognition receptors
               C-type lectin receptors
                CLEC4C (BDCA2, CD303)
                 D12232  Litifilimab (USAN)
DBLINKS     CAS: 2407378-48-5
///
